Search Results for 'Causes of schizophrenia'

NUI Galway has been awarded a European Research Council Starting Grant of almost €1.5 million over five years from Horizon 2020’s European Research Council, to identify a new biological target for new treatment development of schizophrenia.

A novel rare risk factor linked to mental illnesses such as schizophrenia has been identified by a multi-institutional team led by Professor Sanbing Shen of the Regenerative Medicine Institute (REMEDI) at NUI Galway.